<

 
Data updated 2025-06-03 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date11730112.7 (espacenet)  (Federated)  (European Patent Register), 20110311
Patent/reg. no. and dateDK/EP 2544680, 20150114
Publication date20130116
Priority no. and dateUS 312895 P, 20100311
EP pub. no. and date EP 2544680 20130116
Effective date
Applicant/ownerMerrimack Pharmaceuticals, Inc., One Kendall Square
Suite B7201
Cambridge, MA 02139, US
Applicant ref. no.P015922EPDK1 EJ/GB
InventorGARCIA, Gabriela, 14 Knoll St.
Roslindale, MA 02131, US,
MOYO, Victor, 1694 Main Street, Apt. 5
Concord, MA 01742, US
RepresentativeCHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK
Opponent
IPC ClassA61K 31/337 (2006.01) , A61K 31/517 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C07K 16/32 (2006.01) 
TitleANVENDELSE AF ERBB3-HÆMMERE I BEHANDLINGEN AF TRIPLE-NEGATIV BRYSTCANCER
Int. application no.US2011028129
Int. publication no.WO2011112953
Related patent (certificate)
StatusOphævet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact